Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Lurbinectedin
Trade Name Zepzelca
Synonyms PM01183
Drug Descriptions

Zepzelca (lurbinectedin) is an alkaloid analogue that binds to the minor groove of DNA, resulting in delayed cell cycle progression and cell death (PMID: 20977459). Zepzelca (lurbinectedin) is an FDA-approved chemotherapy agent (FDA.gov).

DrugClasses Chemotherapy - Alkylating 18
CAS Registry Number 497871-47-3
NCIT ID C82382

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Atezolizumab + Carboplatin + Etoposide + Lurbinectedin Atezolizumab Carboplatin Etoposide Lurbinectedin 0 1
Atezolizumab + Lurbinectedin Atezolizumab Lurbinectedin 0 1
Avelumab + Lurbinectedin Avelumab Lurbinectedin 0 1
Berzosertib + Lurbinectedin Berzosertib Lurbinectedin 0 1
Bevacizumab + Lurbinectedin + Paclitaxel Bevacizumab Lurbinectedin Paclitaxel 0 2
Doxorubicin + Lurbinectedin Doxorubicin Lurbinectedin 0 1
Durvalumab + Lurbinectedin Durvalumab Lurbinectedin 0 1
Ipilimumab + Lurbinectedin + Nivolumab Ipilimumab Lurbinectedin Nivolumab 0 1
Irinotecan + Lurbinectedin Irinotecan Lurbinectedin 0 1
Lurbinectedin Lurbinectedin 0 7
Lurbinectedin + Paclitaxel Lurbinectedin Paclitaxel 0 1
Lurbinectedin + Pembrolizumab Lurbinectedin Pembrolizumab 0 1
Lurbinectedin + Trilaciclib Lurbinectedin Trilaciclib 0 1


Additional content available in CKB BOOST